[Capacitance vessels in normal and pathological states].
D000109:Acetylcholine / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure; D001808:Blood Vessels / Q000187:drug effects / Q000503:physiopathology*; D004108:Dilatation, Pathologic; D004558:Electric Stimulation; D004837:Epinephrine / Q000494:pharmacology; D005730:Ganglionic Blockers / Q000494:pharmacology; D006470:Hemorrhage / Q000503:physiopathology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006801:Humans; D009203:Myocardial Infarction / Q000503:physiopathology; D009476:Neurons, Efferent; D005996:Nitroglycerin / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000502:physiology; D011941:Receptors, Adrenergic; D012018:Reflex; D012770:Shock, Cardiogenic / Q000503:physiopathology; D012774:Shock, Traumatic / Q000503:physiopathology; D014655:Vascular Resistance; D014666:Vasomotor System / Q000503:physiopathology*; D014680:Veins / Q000187:drug effects / Q000503:physiopathology
D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D011941:Receptors, Adrenergic; D000804:Angiotensin II; D000255:Adenosine Triphosphate; D010208:Papaverine; D005996:Nitroglycerin; D000109:Acetylcholine; D009638:Norepinephrine; D004837:Epinephrine
Emkostnye sosudy v norme i pri patologii